LEASE AGREEMENT
Part of 270 Longwood Road South, Hamilton
Pursuant to theShort Form of Leases Act, THIS LEASE AGREEMENT is dated this 1st day of August 2018
BETWEEN:
McMASTER UNIVERSITY
(hereinafter called the “Landlord’’)
OF THE FIRST PART,
- AND-
FUSION PHARMACEUTICALS INC.,
(hereinafter called the “Tenant”)
OF THE SECOND PART
WHEREASThe Gore District Land Trustee Corporation(“Gore”)is the registered owner of the lands upon which the McMaster Innovation Park(“M1P”)is situated within the City of Hamilton (the“MIP Lands”);
AND WHEREASGore and The First Longwood Innovation Trust(“FLIT”)have entered into a headlease with respect to that portion of the MIP Lands located to the west of Longwood Road South (the“Lands ‘)dated January 1, 2011 for a term of 49 years and six months (the“Headlease”);
AND WHEREASFLIT has entered into a sublease dated October 1, 2016 with First Longwood Warehouse Redevelopment GP Corporation(“FLWR”)for all of the building located at200-270 Longwood Road South (the“Building”)on the MIP Lands and a leasehold parcel described on Schedule “A” attached hereto;
AND WHEREASFLWR has entered into a sublease with the Landlord dated June 29, 2016 for certain premises in the Building as set out herein (the“Landlord Premises”);
AND WHEREASthe Landlord desires to lease and licence approximately 5,415 net assignable square feet of the Landlord Premises to the Tenant and the Tenant wishes to lease and license that portion of the Landlord Premises from the Landlord;
AND WHEREASthe Landlord and the Tenant wish to set out the terms and conditions under which the Landlord will make available certain space in the Building as described herein;
AND WHEREASthe Tenant intends on using the herein demised Premises under conditions typical for work involving pharmaceutical and radiopharmaceutical substances for the purpose of discovering, developing, manufacturing, storing, distributing for the purposes of commercialization and future sale pharmaceutical products that may contain radioactive isotopes (radiopharmaceuticals) and other chemical or biological substances. This includes all associated office and laboratory functions typical of leading pharmaceutical companies, which may include work with biohazards (cells, bacteria, etc.) as preclinical models needed to develop new products and receive regulatory approvals, and ancillary administrative offices.
NOW THEREFOREthis lease and licence witnesses that in consideration of the mutual covenants and agreements herein contained and subject to terms and conditions set forth herein, the parties hereto agree as follows:
3